Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Costea, Irina ^a,b   Mack, David R ^c   Israel, David ^d   Morgan, Kenneth ^e   Krupoves, Alfreda ^b,f   Seidman, Ernest ^e   Deslandres, Colette ^b,f   Lambrette, Philippe ^b   Grimard, Guy ^b,f   Levy, Emile ^b,f   Amre, Devendra K ^b,f  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

^e RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; POLYUNSATURATED FATTY ACID; LEUKOTRIENE B4; UNSATURATED FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; FATTY ACID METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; CANADA; GENETICS; METABOLISM;

ADOLESCENT; ADULT; CANADA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FATTY ACIDS, UNSATURATED; FEMALE; GENETIC VARIATION; HAPLOTYPES; HUMANS; INFLAMMATION; LEUKOTRIENE B4; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78650920450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015672     Document Type: Article

References (45)

1. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, et al. (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101: 1559-1568.
2. Lowe AM, Roy PO, Poulin M, Michel P, Bitton A, et al. (2009) Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis 15: 429-435.
3. Kim SC, Ferry GD (2004) Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 126: 1550-1560.
4. Mamula P, Markowitz JE, Baldassano RN (2003) Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 32: 967-995.
5. Van LJ, Russell RK, Drummond HE, Aldhous MC, Round NK, et al. (2008) Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135: 1114-1122.
6. Massey D, Parkes M (2007) Common pathways in Crohn's disease and other inflammatory diseases revealed by genomics. Gut 56: 1489-1492.
7. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
8. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, et al. (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40: 1211-1215.
9. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, et al. (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41: 1335-1340.
10. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, et al. (2007) Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 102: 2016-2025.
11. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, et al. (2000) Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 71: 339S-342S.
12. Calder PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S.
13. Amre DK, Seidman EG (2003) Etiopathogenesis of pediatric Crohn's disease. Biologic pathways based on interactions between genetic and environmental factors. Med Hypotheses 60: 344-350.
14. MacLean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, et al. (2005) Systematic review of the effects of n23 fatty acids in inflammatory bowel disease. Am J Clin Nutr 82: 611-619.
15. Kinsella JE, Lokesh B, Broughton S, Whelan J (1990) Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6: 24-44.
16. Sharon P, Stenson WF (1984) Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453-460.
17. Hawthorne AB, Boughton-Smith NK, Whittle BJ, Hawkey CJ (1992) Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C. Gut 33: 513-517.
18. Jupp J, Hillier K, Elliott DH, Fine DR, Bateman AC, et al. (2007) Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis 13: 537-546.
19. Hardwick JP (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 75: 2263-2275.
20. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170: 2-6.
21. Sands BE (2004) From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 126: 1518-1532.
22. Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-753.
23. Amre DK, Mack DR, Morgan K, Israel D, Deslandres C, et al. (2010) Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther 31: 1186-1191.
24. Amre DK, Mack DR, Morgan K, Israel D, Deslandres C, et al. (2010) Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. Hum Genet 128: 131-135.
25. Amre DK, Mack DR, Morgan K, Krupoves A, Costea I, et al. (2009) Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis 15: 501-507.
26. Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, et al. (2009) Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther 29: 1025-1031.
27. Amre DK, Mack DR, Israel D, Morgan K, Lambrette P, et al. (2008) Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol 103: 615-620.
28. Amre DK, Mack DR, Morgan K, Fujiwara M, Israel D, et al. (2009) Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am J Gastroenterol 104: 2824-2828.
29. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
30. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66: 1863-1870.
31. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, et al. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13: 763-770.
32. Low JH, Williams FA, Yang X, Cullen S, Colley J, et al. (2004) Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflamm Bowel Dis 10: 173-181.
33. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J (1986) Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91: 837-844.
34. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J (1988) In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 95: 11-17.
35. Lobos EA, Sharon P, Stenson WF (1987) Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4. Dig Dis Sci 32: 1380-1388.
36. Ikehata A, Hiwatashi N, Kinouchi Y, Ito K, Yamazaki H, et al. (1993) Leukotriene B4 omega-hydroxylase activity in polymorphonuclear leukocytes from patients with inflammatory bowel disease. Prostaglandins Leukot Essent Fatty Acids 49: 489-494.
37. Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Ito K, et al. (1995) Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease. Scand J Gastroenterol 30: 44-49.
38. Kikuta Y, Kusunose E, Kusunose M (2002) Prostaglandin and leukotriene v-hydroxylases. Prostaglandins Other Lipid Mediat 68-69: 345-362.
39. Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fujii T, et al. (2001) CDNA cloning and expression of a novel cytochrome p450 (CYP4F12) from human small intestine. Biochem Biophys Res Commun 280: 1135-1141.
40. Hendel J, Ahnfelt-Ronne I, Nielsen OH (2002) Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel disease. Inflamm Res 51: 423-426.
41. Tello-Ruiz MK, Curley C, DelMonte T, Giallourakis C, Kirby A, et al. (2006) Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur J Hum Genet 14: 780-790.
42. Curley CR, Monsuur AJ, Wapenaar MC, Rioux JD, Wijmenga C (2006) A functional candidate screen for coeliac disease genes. Eur J Hum Genet 14: 1215-1222.
43. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220.
44. Murakami M, Yoshihara K, Shimbara S, Lambeau G, Singer A, et al. (2002) Arachidonate release and eicosanoid generation by group IIE phospholipase A(2). Biochem Biophys Res Commun 292: 689-696.
45. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202-1207.